Binxian Wei - 11 Jun 2023 Form 4 Insider Report for PALISADE BIO, INC. (PALI)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PALI	Restricted Stock Units	Award	$0	+6,980		$0.000000	6,980	11 Jun 2023	Common Stock	6,980		Direct	F1, F2, F3, F4
transaction	PALI	Common Stock Options	Award	$0	+9,580		$0.000000	9,580	11 Jun 2023	Common Stock	9,580	$1.60	Direct	F1, F2, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Represents partial compensation for services rendered as a director pursuant to Issuer's director compensation policy, which includes 5,100 restricted stock units and 7,000 common stock purchase options. The grants were issued from the Issuer's 2021 Equity Incentive Plan. In addition, Reporting Person received, per its election, an additional 1,880 restricted stock units and 2,580 common stock purchase options as a discretionary grant.
F2	The grants vest fully on the one (1) year anniversary of the grant date.
F3	Each restricted stock unit represents the right to receive one share of common stock.
F4	N/A
F5	Each option represents the right to purchase one share of common stock at the exercise price.